Yechun Xu
Chinese Academy of Sciences · 16 works · 3,138 citations · h-index 9
Top works
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
- Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
- Steered Molecular Dynamics Simulation on the Binding of NNRTI to HIV-1 RT
- Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
- Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease
- Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
- Drug discovery and development targeting the life cycle of SARS-CoV-2
- Recent Progress in Drug Development against COVID-19
- Orthosteric–allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer
- SARS-CoV-2 3CL protease (3CLpro) in complex with myricetin
- Correction to “Conformational Dynamics of the Nicotinic Acetylcholine Receptor Channel: A 35-ns Molecular Dynamics Simulation Study”
- Small Molecule Thioesters as SARS-CoV-2 Main Protease inhibitors: Enzyme inhibition and mechanism, structure-activity relationship, antiviral activity, and X-ray structure determination
- Corrigendum to “Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer” [J. Adv. Res. 84 (2026) 1105–1126]
- SARS-CoV-2 3CL protease (3CLpro) in complex with 7-O-methyl-dihydromyricetin